DVA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
DaVita Inc (DVA) is not a strong buy for a beginner, long-term investor at this moment. While the company has shown some positive financial metrics such as revenue growth and EPS improvement, the negative sentiment from insider and hedge fund selling, coupled with a lack of strong technical or proprietary trading signals, suggests it is better to hold off on investing right now. Additionally, the options data indicates bearish sentiment, and the stock's recent price trend does not provide a compelling entry point for a long-term investor.
The technical indicators present mixed signals. While the moving averages are bullish (SMA_5 > SMA_20 > SMA_200), the MACD is negatively expanding (-0.892), and the RSI is neutral at 47.046. The stock is trading below the pivot level of 152.548, with key support at 147.422 and resistance at 157.675. This suggests limited upward momentum in the short term.
Revenue increased by 9.87% YoY in Q4
EPS grew by 6.47% YoY, and gross margin improved by 4.09%.
Analysts have raised price targets, with UBS projecting a high target of $190, citing strong EPS growth and accretive acquisitions.
Hedge funds and insiders are selling significantly, with hedge fund selling up 6939.07% and insider selling up 267.89%.
Net income dropped by 9.68% YoY in Q4
The MACD and RSI do not indicate strong upward momentum.
Options data reflects bearish sentiment with high put-call ratios.
In Q4 2025, DaVita's revenue increased by 9.87% YoY to $3.62 billion, and EPS grew by 6.47% YoY to 3.29. However, net income dropped by 9.68% YoY to $234.2 million, indicating some profitability challenges. Gross margin improved to 28.28%, up 4.09% YoY.
Analysts have mixed ratings. UBS maintains a Buy rating with a price target of $190, citing strong 2026 guidance and EPS growth. Other firms like Truist and TD Cowen have Hold ratings with price targets of $158 and $144, respectively, reflecting cautious optimism. Barclays also raised its target to $158, emphasizing earnings outlook improvements.
